Trial Profile

Human Metabolism of Ornithine Phenylacetate: A Study in Healthy Volunteers

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 13 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ornithine phenylacetate (Primary)
Indications Hepatic encephalopathy; Liver cirrhosis; Liver failure; Non-alcoholic fatty liver disease
Focus Pharmacokinetics
Acronyms OCERA OP

Most Recent Events

30 Sep 2025 Actual primary completion date changed from 1 Apr 2015 to 30 Apr 2015.
30 Sep 2025 Status changed from active, no longer recruiting to completed.
10 Apr 2019 Planned End Date changed from 1 Apr 2018 to 1 Apr 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com